Page 563 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 563

C H A P T E R          36 

           DISORDERS OF IRON HOMEOSTASIS:  

           IRON DEFICIENCY AND OVERLOAD


           Gary M. Brittenham





        Iron is an essential nutrient required by every cell in the body. Both   on Control of Iron Homeostasis by Hepcidin and Ferroportin and
        decreases  and  increases  in  the  amount  of  iron  may  be  clinically   Chapter 35).
        important. If too little iron is available (iron deficiency), limitations
        on the synthesis of physiologically active iron-containing compounds
        can have harmful consequences. If too much iron accumulates (iron   Direct Measures
        overload)  and  exceeds  the  body’s  capacity  for  safe  transport  and
        storage,  iron  toxicity  may  produce  widespread  organ  damage  and   The direct measures of body iron status yield quantitative, specific,
        death. The body, with no effective means to excrete excess iron, relies   and sensitive determinations of body or tissue iron stores. Quantita-
        upon  control  of  iron  absorption  to  maintain  homeostasis.  This   tive phlebotomy provides a direct measure of total mobilizable storage
        chapter focuses on the clinical application of recent remarkable pro-  iron. Quantitative phlebotomy is inapplicable to most anemic disor-
        gress in understanding the molecular mechanisms that preserve iron   ders but occasionally is useful in the diagnostic evaluation of some
        balance.                                              forms of iron overload (e.g., in patients with hereditary hemochro-
           Iron  disorders  are  principally  abnormalities  in  the  amount  or   matosis who do not undergo liver biopsy). Bone marrow aspiration
        distribution  of  body  iron.  A  fundamental  advance  has  been  the   and biopsy can provide information about (1) macrophage storage
        recognition  that  the  interaction  of  hepcidin,  the  iron  regulatory   iron by semiquantitative grading of marrow hemosiderin stained with
        hormone,  with  ferroportin,  the  cellular  iron  export  channel,  is   Prussian blue (Fig. 36.2) or, if needed, by chemical measurement of
        primarily responsible for the quantity and tissue disposition of body   nonheme iron; (2) iron supply to erythroid precursors by determining
        iron. Hepcidin controls iron absorption, use, and storage by binding   the proportion and morphology of marrow sideroblasts (i.e., normo-
        to  and  inducing  the  degradation  of  ferroportin,  decreasing  iron   blasts with visible aggregates of iron in the cytoplasm); and (3) general
        entry  into  plasma  from  macrophages,  hepatocytes,  and  intestinal   morphologic features of hematopoiesis. Bone marrow aspiration and
        enterocytes (see box on Control of Iron Homeostasis by Hepcidin   biopsy are useful in studies of iron deficiency, but they are of limited
        and Ferroportin and Chapter 35). Hepcidin expression is suppressed   applicability in the evaluation of iron overload because no informa-
        with iron deficiency, hypoxia, or increased erythropoietic demand but   tion about the extent of hepatocyte iron deposition is provided. In
        stimulated with iron overload, inflammation, or infection. Genetic   the evaluation of iron overload, liver biopsy is the best direct test for
        and acquired disorders with a deficiency in hepcidin production or   assessing iron deposition, permitting quantitative measurement of the
        with ferroportin resistance to hepcidin action produce iron overload.   nonheme iron concentration and histochemical examination of the
        Hepcidin  excess  due  to  genetic  causes  produces  iron-deficiency   pattern  of  iron  accumulation  in  hepatocytes  and  macrophages
        anemia,  but  acquired  forms,  such  as  those  associated  with  infec-  (Kupffer cells).
        tion, inflammation, or malignancy, result in iron sequestration and     Direct methods for assessing iron status have the disadvantages of
        anemia.                                               being invasive procedures, with their attendant discomfort, lack of
                                                              acceptability to patients, and, in the case of liver biopsy, risk. A variety
                                                              of noninvasive means of measuring tissue iron stores has been devel-
        LABORATORY EVALUATION OF IRON STATUS                  oped  and  applied  in  clinical  studies,  including  determination  of
                                                              hepatic magnetic susceptibility, computed tomography, and magnetic
        Because iron disorders primarily produce quantitative abnormalities   resonance imaging (MRI). MRI, the most widely available method,
        in the amount and tissue distribution of iron, laboratory evaluation   can provide information about iron deposition in the liver, spleen,
                                                                                 4
        of  iron  status  relies  on  indicators  of  iron  supply  and  storage. The   pancreas, heart, and brain.  When available as appropriately calibrated
        principal routes of iron movement, the amounts and distribution of   and validated techniques, these noninvasive methods are helpful in
        the major iron pools, and the sites of hepcidin control of iron entry   the diagnosis and management of iron overload, but, they lack the
        into plasma are shown in Fig. 35.1. The continuum of changes with   accuracy required to detect iron deficiency.
        increased or decreased body iron content is illustrated in Fig. 36.1,
        which shows schematically the amounts of erythroid iron and storage
        iron together with the division of iron stores between hepatocyte and   Indirect Measures
        reticuloendothelial  macrophage  deposits  and  with  characteristic
        values for some clinically available indicators of iron status.  Indirect measures of body iron status have the advantages of ease and
           Body iron supply and stores can be evaluated by both direct and   convenience,  but  all  are  subject  to  extraneous  influences  and  lack
        indirect means, but no single indicator or combination of indicators   specificity,  sensitivity,  or  both.  When  used  to  estimate  body  iron
        is ideal for evaluation of iron status in all clinical circumstances. As   stores, all of the available indirect measures are influenced not only
        body  iron  content  decreases  from  the  iron-replete  normal  to  the   by total body iron stores but also by the effects of acute or chronic
        amounts  found  in  iron-deficiency  anemia  or  as  it  increases  to  the   changes in plasma hepcidin (see box on Control of Iron Homeostasis
        magnitudes found in the various forms of iron overload, each avail-  by Hepcidin and Ferroportin). Assays for plasma and urinary hepci-
        able measure reflects in a different manner the continuum of changes   din are not yet generally available for clinical use, but they are under
        shown in Fig. 36.1. In addition, each indicator may be affected by   development and will likely be helpful in the evaluation of patients
        coexisting  conditions  that  modulate  hepcidin  expression,  such  as   with disorders of iron homeostasis.
        infection,  inflammation,  cellular  injury,  malignancy,  ineffective   Measurement  of  the  plasma  ferritin  concentration  provides  the
        erythropoiesis, hypoxemia, liver disease, and malnutrition (see box   most useful indirect estimate of body iron stores. The small amounts

        478
   558   559   560   561   562   563   564   565   566   567   568